TECH Stock Analysis: Buy, Sell, or Hold?
TECH - Bio-Techne Corp.
$72.32
0.04 (0.06%)
▲
5d:
-0.11%
30d:
+0.77%
90d:
+52.67%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When TECH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TECH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TECH shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$28.21
Based on -7.2% avg growth
INTRINSIC VALUE TODAY
$17.52
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TECH is currently trading at $72.32, which is considered extended relative to its 30-day fair value range of $71.66 to $72.30. From a valuation perspective, the stock is trading at a premium (Forward PE: 43.3) compared to its historical average (28.4). At these levels, the market is pricing in 15.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $72.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $72.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$71.66 -
$72.30
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.2%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($70.73)
- NEUTRAL: PE elevated vs history but 15.1% growth expectation is conservative given 129% recent growth
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$71.66 -
$72.30
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$72.00
Resistance Level
$72.62
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
43.28
Wall Street Target
$70.73
(-2.1%)
Revenue Growth (YoY)
1.3%
Earnings Growth (YoY)
128.6%
Profit Margin
15.0%
Valuation Premium vs History
+15.1% premium
PE vs Historical
43.3 vs 28.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+15.1%
(market-implied from PE analysis)
1-Year Target
$83.19
(+15%)
2-Year Target
$95.76
(+33%)
3-Year Target
$110.22
(+53%)
3-Yr Target (if PE normalizes)
(PE: 43→28)
PE COMPRESSION
$72.32
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 43.3, Growth: -18.4%)
$52.69
(+-27%)
Base:
(SPY PE: 20.1, Growth: -18.4%)
$24.43
(-66%)
Bear:
(PE: 17.1, Growth: -18.4%)
$20.77
(-71%)
📈
Valuation based on Current Earnings
Forward PE: 34.48 | Forward EPS (Implied): $2.10
Bull Case
$87.33
(+21%)
Analyst growth 15.0%, PE expands to 36.2
Base Case
$72.32
(0%)
Market implied 0.0%, PE stable at 34.5
Bear Case
$55.32
(-24%)
Severe decline -15.0%, PE contracts to 31.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 5:04 AM ET
Data refreshes hourly during market hours. Next update: 6:04 AM
Data refreshes hourly during market hours. Next update: 6:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TECH showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-03-30
April McClain Delaney
SELL
2026-03-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
